1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
36
1d
2 29
1d
25
36
Lauren A Beslow, MD, MSCE
70Associate Professor of Neurology at the Children's Hospital of Philadelphia
7
60
Department: Neurology
4
1
b
1d
46
Contact information
51
4
3
3
1d
51
Children's Hospital of Philadelphia
1d Division of Neurology
3e 3401 Civic Center Boulevard
Philadelphia, PA 19104
26
1d Division of Neurology
3e 3401 Civic Center Boulevard
Philadelphia, PA 19104
35
f
18
Publications
23 a
3
2
29
23 a
Links
e4 Search PubMed for articles
72 Stroke Editorial Board
7d Neurology Editorial Board
85 Pediatric Stroke Reviewer and Editorial Board
94 Pediatric Neurology Editorial Board
fa One of Stroke's bloggers, Dr. Kevin O'Connor selected one of Dr. Beslow's first author articles for the subject of a blog for Stroke's social media platform
ae Annals of the Child Neurology Society Editorial Board
c4 Scopus h-index for Publications 32
d9 International Pediatric Stroke Organization Blog - COVID-19 and Pediatric Stroke
90 Penn Center of Excellence for Cerebral Cavernous Malformations
c
4
b
1f
e4 Search PubMed for articles
72 Stroke Editorial Board
7d Neurology Editorial Board
85 Pediatric Stroke Reviewer and Editorial Board
94 Pediatric Neurology Editorial Board
fa One of Stroke's bloggers, Dr. Kevin O'Connor selected one of Dr. Beslow's first author articles for the subject of a blog for Stroke's social media platform
ae Annals of the Child Neurology Society Editorial Board
c4 Scopus h-index for Publications 32
d9 International Pediatric Stroke Organization Blog - COVID-19 and Pediatric Stroke
90 Penn Center of Excellence for Cerebral Cavernous Malformations
c
13
Education:
21 9 B.S. 23 (Biology (neurobiology)) c
28 Yale University, 1999.
21 9 M.D. 15 (Medicine) c
3f Stanford University School of Medicine, 2003.
21 d M.S.C.E. 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 2011.
c
3
3
21
21 9 B.S. 23 (Biology (neurobiology)) c
28 Yale University, 1999.
21 9 M.D. 15 (Medicine) c
3f Stanford University School of Medicine, 2003.
21 d M.S.C.E. 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 2011.
c
1f
Post-Graduate Training
24 63 Intern in General Pediatrics, The Children's Hospital of Philadelphia, 2003-2004.
24 65 Resident in General Pediatrics, The Children's Hospital of Philadelphia, 2004-2005.
24 95 Resident in Child Neurology, The Hospital of the University of Pennsylvania and The Children's Hospital of Philadelphia, 2005-2008.
24 5e Pediatric Stroke Fellow, The Children's Hospital of Philadelphia, 2008-2009.
24 86 Postdoctoral Research Fellow in Neurodevelopmental Disabilities, The Children's Hospital of Philadelphia, 2009-2011.
24 92 Faculty Fellow, Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, PA, 2011-2012.
c
3
25
24 63 Intern in General Pediatrics, The Children's Hospital of Philadelphia, 2003-2004.
24 65 Resident in General Pediatrics, The Children's Hospital of Philadelphia, 2004-2005.
24 95 Resident in Child Neurology, The Hospital of the University of Pennsylvania and The Children's Hospital of Philadelphia, 2005-2008.
24 5e Pediatric Stroke Fellow, The Children's Hospital of Philadelphia, 2008-2009.
24 86 Postdoctoral Research Fellow in Neurodevelopmental Disabilities, The Children's Hospital of Philadelphia, 2009-2011.
24 92 Faculty Fellow, Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, PA, 2011-2012.
c
17
Certifications
28 7c American Board of Psychiatry and Neurology: Neurology with special qualification in child neurology, 2008.
c
3
8d
Permanent link28 7c American Board of Psychiatry and Neurology: Neurology with special qualification in child neurology, 2008.
c
2 29
21
1e
1d
24
5e
8
38c Dr. Beslow has been a member of the International Pediatric Stroke Study (IPSS) since 2007 and has leadership positions in the IPSS and International Pediatric Stroke Organization (IPSO). She also participates in multiple studies including pediatric stroke clinical trials and is the Chair of the IPSO Outcomes Working Group. Dr. Beslow has led several studies on pediatric stroke in the setting of COVID-19 and has several active projects related to pediatric stroke, pediatric brain vascular malformations, and hereditary hemorrhagic telangiectasia (HHT). Dr. Beslow is a part of several centers of excellence and special programs related to brain vascular disease including the Penn HHT Center Center of Excellence, Penn Cerebral Cavernous Malformation (CCM) Center, CHOP Comprehensive Vascular Anomalies Program (CVAP), and CHOP Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED).
8
de Pediatric Stroke: risk factors, measurement tool validation for pediatric stroke and cerebrovascular malformations, predictors of outcome, COVID-19 and pediatric stroke, neurovascular effects of sickle cell disease
8
90 Pediatric cerebral vascular malformations; hereditary hemorrhagic telangiectasia, cerebral cavernous malformations, Sturge Weber Syndrome
65
21b and brain vascular malformations like AVMs and cavernous malformations. She has a special interest in HHT and was a research fellow with the Brain Vascular Malformation Consortium's HHT project. In addition to the CHOP Pediatric Stroke Program, Dr. Beslow is a part of several Centers of Excellence and special programs related to brain vascular disease including the Penn HHT Center and CHOP HHT Clinic, Penn CCM Center, CHOP Complex Vascular Anomalies Program, and CHOP Sickle Cell and Red Cell Disorders Curative Therapy Center.
8
1ff Pediatric Stroke, Pediatric Cerebral Vascular Malformations (neurology member of the Comprehensive Vascular Anomalies Program [CVAP], Hereditary Hemorrhagic Telangiectasia (HHT), Cerebral Cavernous Malformations (CCMs) (https://www.angioma.org/penn-medicine/?amp), Cerebrovascular Effects of Sickle Cell Disease (neurology consultant to Sickle Cell and Red Cell Disorder Curative Therapy Center [CuRED]), Hypoxic Ischemic Encephalopathy, Pediatric Neurocritical Care Consultation, General Child Neurology
62
e 7 1d 1f
27
Description of Research Expertise
137 Dr. Beslow’s research focuses on neonatal and childhood cerebrovascular diseases including various stroke subtypes (arterial ischemic stroke, hemorrhagic stroke, cerebral sinovenous thrombosis), arteriopathies (e.g. focal cerebral arteriopathy, moyamoya), and cerebral vascular malformations.8
38c Dr. Beslow has been a member of the International Pediatric Stroke Study (IPSS) since 2007 and has leadership positions in the IPSS and International Pediatric Stroke Organization (IPSO). She also participates in multiple studies including pediatric stroke clinical trials and is the Chair of the IPSO Outcomes Working Group. Dr. Beslow has led several studies on pediatric stroke in the setting of COVID-19 and has several active projects related to pediatric stroke, pediatric brain vascular malformations, and hereditary hemorrhagic telangiectasia (HHT). Dr. Beslow is a part of several centers of excellence and special programs related to brain vascular disease including the Penn HHT Center Center of Excellence, Penn Cerebral Cavernous Malformation (CCM) Center, CHOP Comprehensive Vascular Anomalies Program (CVAP), and CHOP Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED).
8
de Pediatric Stroke: risk factors, measurement tool validation for pediatric stroke and cerebrovascular malformations, predictors of outcome, COVID-19 and pediatric stroke, neurovascular effects of sickle cell disease
8
90 Pediatric cerebral vascular malformations; hereditary hemorrhagic telangiectasia, cerebral cavernous malformations, Sturge Weber Syndrome
65
Description of Clinical Expertise
147 Dr. Beslow is a member of the CHOP Pediatric Stroke Program and completed a clinical and research fellowship in pediatric stroke. She also is a neurology consultant in the CHOP pediatric, neonatal, and cardiac intensive care units. Dr. Beslow's clinics focus on pediatric stroke, arteriopathies like moyamoya,21b and brain vascular malformations like AVMs and cavernous malformations. She has a special interest in HHT and was a research fellow with the Brain Vascular Malformation Consortium's HHT project. In addition to the CHOP Pediatric Stroke Program, Dr. Beslow is a part of several Centers of Excellence and special programs related to brain vascular disease including the Penn HHT Center and CHOP HHT Clinic, Penn CCM Center, CHOP Complex Vascular Anomalies Program, and CHOP Sickle Cell and Red Cell Disorders Curative Therapy Center.
8
1ff Pediatric Stroke, Pediatric Cerebral Vascular Malformations (neurology member of the Comprehensive Vascular Anomalies Program [CVAP], Hereditary Hemorrhagic Telangiectasia (HHT), Cerebral Cavernous Malformations (CCMs) (https://www.angioma.org/penn-medicine/?amp), Cerebrovascular Effects of Sickle Cell Disease (neurology consultant to Sickle Cell and Red Cell Disorder Curative Therapy Center [CuRED]), Hypoxic Ischemic Encephalopathy, Pediatric Neurocritical Care Consultation, General Child Neurology
62
Description of Other Expertise
34 Board eligible in General Pediatricse 7 1d 1f